NBC started broadcasting Transplant in the fall of 2020 due to the delay of its own series due to the pandemic. The drama has already been renewed for a third season in Canada and Transplant costs less for the peacock network to air than its regular shows. Will the show continue to have a home in the United States or will it be cancelled? Stay tuned.
Canadian medical drama series, The Transplant The TV show stars Hamza Haq, Laurence Leboeuf, John Hannah, Jim Watson, Ayisha Issa, Linda E. Smith, Torri Higginson, Gord Rand, Nora Guerch and Ahmad Meree. Doctor Bashir Hamed (Haq) is a charismatic Syrian doctor with proven skills in emergency medicine. He and his younger sister, Amira (Gulamgaus), flee their war-torn homeland and become refugees, struggling to forge a new life in Canada. When a horrific truck accident nearly kills a senior doctor right in front of him, Bash saves the doctor’s life and earns a residency in the biggest emergency department at Toronto’s top hospital. Bash tries to meet the demands of his new country and a new job, all the while trying to pay the bills, raise his little sister, and carve out a new life for the two of them in this unfamiliar land. In season two, boss Dr. Jed Bishop (Hannah) suffers a stroke, and Bash and his team must adjust to both new co-workers and new challenges..
Ratings are usually the best indication of a show’s chances of staying on the air. The higher the odds, the better the chances of survival. This table will be updated as new ranking data becomes available.
Update 3/7: You can see last night’s notes in context.
To note: If you don’t see the updated chart, try reloading the page or check it here.
For comparisons: First season of Transplant on NBC averaged a 0.44 rating in the 18-49 demographic and 3.50 million viewers in Live Ratings+ on the same day.
To note: These are the final national rankings, including all Live+ same-day viewing and DVR playback (until 3:00 a.m.). Early Affiliate Quick Ratings (Estimates) are marked with an “*”. Although these numbers do not include delayed or streaming viewing, they are a very good indicator of a show’s performance, especially when compared to others on the same channel. There may be other economic factors involved in a show’s fate, but higher-rated series are usually renewed and lower-rated ones are canceled.
What do you think? do you like it Transplant TV shows on NBC? Should it be canceled or resumed for a third season on NBC?